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Introduction
Peripartum cardiomyopathy (PPCM) is “an idiopathic 
cardiomyopathy presenting with heart failure (HF) secondary 
to left ventricular (LV) systolic dysfunction towards the end of 
pregnancy or in the months following delivery, where no other 
cause of HF is found. It is a diagnosis of exclusion. The LV may 
not be dilated but the LV Ejection Fraction (LVEF) is nearly always 
reduced below 45%”.[1] Although the disease was first described 
by Gouley and colleagues in 1937, its aetiology is still unknown 
and large scale epidemiologic studies began only recently.[2, 3, 
4] However, several case series of HF around the puerperium 
dating back to 1961, many predating the wide availability of 
echocardiography and most not confirmed with autopsy, have 
been reported from Africa (Table 1). With the availability of 
echocardiography in the late 1970s in parts of Africa however, 
many of those postpartum HF cases were shown not to be due 
to a cardiomyopathy.[5-9] 
Given that African ancestry is believed to be a strong risk factor 
for PPCM, the present article aimed to review the epidemiology 
of the disease in Africa, where the disease is relatively 
more common.[1] 
Epidemiology
PPCM is a global disease with epidemiology that varies widely 
and with multifactorial aetiology. 
Prevalence/incidence of PPCM
The true incidence or prevalence of PPCM in Africa and in some 
other populations is unknown. This is largely because to date there 
is no population-based study on PPCM in Africa, and very few 
such studies were carried out elsewhere. However, from available 
data, PPCM tends to be rare in some parts of the world and more 
common in others.[10-14] For example recent population-based 
studies suggest an estimated incidence of PPCM of 1 in 1,741 
deliveries in South Korea, 1 in 3,790 deliveries (925 patients in 15 
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years) in Taiwan, 1 in 10,149 deliveries in Denmark (61 patients 
in 10 years), 1 in 3,189 live births in the United States of America 
and 1 in 20,000 deliveries in Japan.[10-14]  Studies that estimated 
incidence in Africa used hospital-based data, arriving at values 
such as 1 in 1000 live births in South Africa, 1 in 100 deliveries in 
Sokoto, Nigeria, and 1 in 3,800 in Burkina Faso.[15-17] Prevalence 
of PPCM was also estimated in a multicentre study in Kano, 
Nigeria.[18] It was the most prevalent type of cardiomyopathy 
in Kano, found in 55 out of 1296 patients (4.2%) referred for 
echocardiography over a period of 7 months, representing 52.4% 
of all cardiomyopathies.[18] However, one of the objectives of the 
ongoing Peripartum Cardiomyopathy in Nigeria (PEACE) registry 
is to estimate the burden of PPCM in 20 hospitals spread across 
Nigeria, and the study will be concluded by the end of March 
2019.[4] The ongoing worldwide EURObservational Research 
Programme (EORP) on PPCM has also recruited many patients 
from South Africa, Nigeria, Egypt, Burkina Faso, Democratic 
Republic of Congo and Sudan, and will hopefully provide broad 
overview of epidemiologic data on PPCM in Africa.[3] 
The reasons for the variation in incidence between and 
within countries remain unknown, but probably reflect both 
environmental and genetic factors. 
PPCM risk factors
PPCM has been associated with several risk factors over the 
years, but there is significant inconsistency between studies of 
their association with the disease. The suggested risk factors 
include increased age, gravidity or parity, African origin, pre-
eclampsia, use of tocolytics, twin pregnancy, obesity, poor 
socioeconomic status/malnutrition, customary birth practices 
and selenium deficiency.[19-21] 
Increased age: Although PPCM is thought to be more prevalent 
in the upper and lower extremes of childbearing age, and in older 
women of high parity, it is important to note that the disease could 
affect  such women regardless of their age or parity.[19-22] In our 
recent series comprising of 54 PPCM patients in Kano, Nigeria, 
the age of the patients ranged from 18 to 45 years with a mean 
of 26.6 ± 6.7 years, and 35.2% were between 18 and 20 years, 
and only 20.4% were older than 30 years.[21] In comparison 
to controls  who were lactating mothers from the same locality 
as the patients, increased age was not a risk factor for the 
disease.[23] 
Gravidity/parity: Although several studies have suggested that 
high parity is an important risk factor for PPCM, it is important 
Table 1. Some pioneer studies on peripartum HF in Africa
Study  Country N Echo? Main findings 




23 No The commonest type of idiopathic myocardial failure in Johannesburg in African 
women before the menopause. 
Two-thirds developed symptoms within first 10 weeks postpartum. 
A significant relationship is shown between incidence on the one hand and high 
parity, high childbearing age, and twinning on the other.
Poor prognosis is significantly related to high age and parity; prolonged lactation 
after presentation and presence of cardiomegaly or LVH on ECG.




Nigeria (Ibadan) 50 No The clinical findings are of biventricular myocardial failure with mild transitory 
hypertension. 
Clinical syndrome is more compatible with a hypertensive origin than with intrinsic 
myocardial disease.
Davidson NM, et 
al, 1974.7
Nigeria (Zaria) 224 No PPCF patients recruited from 1969-1972.
96% were Hausa or Fulani in origin, compared with 70% for women admitted to the 
medical wards (Controls).
58 % of the patients lived in rural areas, compared with only 37% of Controls.
Incidence of PPCF in Zaria about 1 % of Hausa deliveries, with a peak in July.
Only 1% of Hausa PPCF patients did not take postpartum baths, 3% did not lie on 
hot beds, and 6% took no “Kanwa” at all.
Authors believed that the customs of Hausa women in Zaria were important in the 
pathogenesis of PPCF, although they may not be wholly responsible for the syndrome
Davidson NM et al, 
1978.8  
Nigeria (Zaria) 224 No Results of 2-5-year follow-up.
Post-partum hypertension was found in 87% of PPCF patients and 61% of Controls.
Digoxin and diuretics were rapidly effective, causing a mean weight loss of 29% in 15 
days, resolution of hypertension, and a fall in the cardio-thoracic ratio (CTR).
During the 1st year after diagnosis, the CTR became normal in 82% of patients, and 
the ECG in 60%. 
PPCF recurred, again with the same seasonal variation, after 19 per cent of 
subsequent pregnancies. 
During follow up for 2 to 5 years, 22% of the patients became hypertensive, and 
11% died. 
The prognosis was worst in those with an arrhythmia, hypertension, sustained 
cardiomegaly or aged 30 or more.
Sanderson JE, et 
al, 1979.9
Nigeria (Zaria) 43 Yes Left ventricular function and systolic time intervals were relatively good.
Estimated cardiac output were high.
Findings not compatible with a severe heart muscle disorder, or cardiomyopathy.
N, total number of patients; ECG, electrocardiogram; LVH, left ventricular hypertrophy; CTR, cardiothoracic ratio; PPCF, peripartum cardiac 
failure. 
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to note that 24–37% of cases may occur in young primigravid/
primiparous patients.[1,3,19-23] Of the 43 patients studied 
in Harare, Zimbabwe, 34.9% were primiparous, and 16.3% 
had parity of 4 or more.[24] The average parity among PPCM 
patients was 2 in South Africa and Burkina Faso, but 4 to 5 in 
Nigeria and up to one-third was primiparous.[16,17,20,21] In 
comparison, PPCM patients in the PPCM EORP recruited from 
European countries had a median parity of 2 and only 18.6% 
were primiparous, while those from non-European countries had 
median parity of 3 and 12.1% were primiparous.[3] In our cohort, 
multiparity was also not associated with PPCM because it was 
even more common in the Control (84%) than PPCM (74.4%) 
groups (p=0.296).[23]  
African origin: There seems to be a strong relationship between 
African ancestry and PPCM, although Elkayam et al clearly 
showed that PPCM in the United States is not limited to black 
women.[25] However, there was a significantly higher incidence 
in African American women as compared with other races.[26] 
Gentry et al conducted a case-control study in Augusta, Georgia, 
and Memphis, and found almost a 16-fold higher incidence 
of PPCM in African American compared with non–African 
American women.[26] Furthermore, African ancestry seems 
to confer worse prognosis among PPCM patients, likely due 
to poorer access to medical care and the presence of guanine 
nucleotide–binding proteins β-3 subunit (GNB3) TT genotype, 
which is more prevalent in blacks and associated with worse 
outcomes.[27] In subset analysis by race, black women with the 
GNB3 TT genotype had a significantly lower mean LVEF at entry 
compared to C allele carriers (0.28±0.09 vs. 0.35± 0.08; p=0.04).
[27] The ongoing worldwide PPCM EORP aims to delineate the 
impact of socioeconomic factors versus ethnicity on a number of 
management and outcome parameters.[3] 
Preeclampsia: It has been suggested that preeclampsia and 
PPCM share a common pathophysiological mechanism that 
leads to the clinical syndrome of HF, and both are possibly related 
to the secretion of antiangiogenic factors, including soluble fms-
like tyrosine kinase-1 (sFLT1) from the placenta in pregnancy.
[28,29] Although epidemiologic studies have reported a strong 
association between preeclampsia and PPCM, with a prevalence 
of preeclampsia in patients with PPCM of about 20%, previous 
studies from Africa have not reported such an association.[16,20-
24,30] It is hoped that the ongoing PEACE Registry in Nigeria will 
shed more light on this.[4] In itself, preeclampsia occurs in 10 % 
of pregnancies in Africa, which is significantly higher than the 
global average of approximately 2 %.[31]
Systemic hypertension: A review by Elkayam described 
hypertension as a strong ‘associated condition’, and not an 
aetiologic factor of PPCM.[32] However, in societies where both 
PPCM and sustained hypertension are common in women, 
differentiating PPCM from hypertensive heart disease could 
be difficult if high blood pressure (BP) is considered a clinical 
feature of PPCM. In support of this point, we found eccentric left 
ventricular hypertrophy, irrespective of gender, to be the most 
common type of abnormal LV geometry in hypertensive subjects 
in Kano, Nigeria.[33] These patients tend to present in HF with 
similar clinical and echocardiographic features to PPCM, except 
for the high BP or history of hypertension.[33] Some PPCM 
registries have shown that high BP in PPCM is rare, as reported 
by Sliwa et al from South Africa (2%) and Fett et al from Haiti (4%).
[34,35] In contrast, we recently found hypertension among 41% 
of untreated PPCM patients and 28% of controls (p=0.197).[23] 
A retrospective study in Japan similarly reported the incidence 
of hypertension in PPCM as 41%, which is substantially higher 
than in the overall pregnant population.[14,36] Moreover, 
Kamiya et al revealed that the hypertension is independently 
associated with a shorter hospital stay and higher LVEF.[14,36] 
However, hypertensive patients with and without PPCM had 
the same LV size and systolic dysfunction at diagnosis and 
discharge. In addition, parameters such as LV systolic diameter, 
fractional shortening, and LVEF showed greater improvement 
in the hypertensive patients. Thus, they concluded that the 
hypertensive state is not causative in the development of PPCM 
and might be a subset of PPCM that is characterized by relatively 
swift recovery, except in fatal cases.[14]. Similarly, Ntusi et al 
showed different modes of recovery in patients presenting with 
PPCM versus those with hypertensive disorders of pregnancy 
presenting with LV dysfunction and HF in a South African cohort.
[37] In addition to important differences in the ages, time of 
onset of HF, clinical, ECG and echocardiographic features, 5 of 
the 30 PPCM patients died over 3.5 years as against none of 
the 53 hypertensive patients over 6 years of follow-up.[37] In a 
retrospective analysis of data from 6 States in the USA, Kao et 
al also reported a significantly higher prevalence of hypertension 
among PPCM patients (46.9%) than Controls (6.4%), and 
considered it a strong PPCM risk factor.[38] Similarly in the 
Investigations of Pregnancy-Associated Cardiomyopathy (IPAC) 
study, hypertension was found in 45% of the PPCM patients and 
was commoner in Blacks (70% Vs 34%) but not associated with 
worse outcomes.[39] Placental ischaemia seems to be the main 
pathogenic mechanism of pregnancy-induced hypertension. 
This is followed by the placental release of vasopressor 
substances that are involved both in generalised endotheliosis 
that characterizes the disease, and in hypertension.[40] From the 
foregoing, it clear that the relationship between hypertension and 
PPCM needs further research. 
Poor socio-economic status/malnutrition: It was observed more 
than 40 years ago that peripartum cardiac failure is a disease that 
predominates among the poor, living in poor social conditions.
[5,8] In Kano (Nigeria), it was also observed that among women 
referred for echocardiography, PPCM almost always occurred in 
women with low income (7.3% Vs 0%).[41] The most plausible 
explanations for this observation could be poor nutrition and 
poor medical care. However, the occurrence of the disease in 
well-nourished patients had put this theory to doubt. A more 
recent study in Kano has further questioned the theory of poor 
socioeconomic status as a risk factor for PPCM by finding no 
significant differences in income and educational level between 
PPCM patients and controls.[23] 
Customary birth practices: About 4 decades ago in Zaria 
(northern Nigeria), women of the Hausa tribe appeared to have 
a high incidence (1:100) of a form of HF within the time frame of 
PPCM, termed postpartum cardiac failure (PPCF).[9,42] This was 
believed to be related to some local Hausa postpartum customary 
practices, mainly twice daily hot baths by new mothers, regular 
ingestion of a thick drink made from millet and rich in dry lake salt, 
‘Kunun Kanwa’ (in Hausa Language), and lying on heated mud 
beds, starting from shortly after giving birth and continuing for 
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about 3 months.[9,42] Although these practices were intended to 
stimulate breastmilk production, protect from the harmful effects 
of “cold” and improve the general wellbeing of the new mother, 
they were also believed to cause significant volume overload and 
vasodilatation, resulting in PPCF.[8,9,42] When echocardiography 
became available in Zaria in the late 1970s, Sanderson et al 
confirmed that PPCF was mainly a “high-output HF with well-
preserved ventricular function”, and not a cardiomyopathy.[9] For 
this reason therefore, PPCF is an entity different from what we 
know today as PPCM, going by the current definition.[1] 
Among a well-characterised cohort of 21 PPCM patients, 
Danbauchi SS reported from Zaria that all of them practised the 
postpartum customs, while Isezuo et al reported from Sokoto 
(northern Nigeria) that up to 81.5% of PPCM patients practised 
the hot baths for at least 30 days.[16,43] When compared with 
apparently healthy controls however, the practices were found to 
be even more common among them than the PPCM patients (hot 
baths, 82% Vs 35.1%; Kunun Kanwa, 78% Vs 23.1%; p<0.001; 
respectively), clearly implying that the practices were simply 
common cultural habits among the Hausas that are not related 
to PPCM.[23] (Figure 1) It is important to note that traditional 
customary birth practices are not limited to the Hausas or Fulanis 
in Nigeria. Okeke et al reported that in the immediate postpartum 
period, 25.2% of 420 women in Enugu, South Eastern Nigeria 
drank various forms of alcoholic beverages to induce lactation 
while 80.2% of them applied hot compresses on the lower 
abdomen to aid lochia drainage and involution of the uterus, 75% 
of them sat in hot salt water solution (sitz bath) in the immediate 
postpartum to aid lochia drainage, aid perineal wound healing 
and improve vaginal tone.[44] Although the results of PEACE 
Registry are still being awaited, it is common knowledge that 
PPCM is relatively more common in northern than other regions 
of Nigeria, and the relevance of the traditional birth practices in 
PPCM would be clarified.[4,7-9] 
Selenium deficiency: Selenium is a naturally occurring element 
found in soil, rocks and water [37]. The selenium content in foods 
principally depends on the concentration and physico-chemical 
forms existing in the soil [45]. However, levels of serum selenium 
are determined by many factors, including its availability in foods, 
absorption, cooking, lactation, alcohol, chronic illnesses, etc 
[37,41]. Cenac et al reported for the first time from Niger Republic, 
where PPCM is an endemic disease, that selenium deficiency 
may be an important problem in Sahelian African patients 
with PPCM, akin to what was described for Keshan disease 
[47,48]. In support of the PPCM selenium theory by Cenac et 
al, our results have shown critically low selenium levels among 
76.9% of the studied PPCM patients [23,47]. Further analysis 
of our data (unpublished) shows that selenium levels increase 
the odds of having PPCM to 1.08 (95% confidence interval = 
1.043- 1.118; p<0.001).[23] North-western Nigeria shares a long 
border, geography and customs with Niger republic, hence the 
common food types and dietary habits, which are the sources 
of selenium. Our results have shown that PPCM patients had 
significantly lower serum selenium levels and significantly higher 
prevalence of rural residency than controls despite similar income 
and educational levels. In addition, rural residency significantly 
increased the odds of having critically low serum selenium 
levels. Our observation of high prevalence of rural residency 
among PPCM patients was similarly made for PPCF decades 
ago in Zaria and Johannesburg.[5,7,8,23] It is well known that in 
Nigeria, most rural residents are subsistence farmers who tend to 
consume the locally produced foods and grown animals. Urban 
residents on the other hand are more exposed to imported foods 
and animals, from regions where there is no selenium deficient 
soil and animals. Therefore, it is reasonable to hypothesize that 
most women in Kano (and the Sahel region) develop PPCM if 
they depend on locally produced foods and animals. The serum 
selenium levels among PPCM patients in Kano (61.7±14.9µg/L) 
and Niamey (48.0±25µg/L) were similar, most likely because 
of their geographical and cultural similarities which explains 
the heavy burden of the disease in the region, in comparison 
with respective values in Haiti of 110µg/L (range 67–145µg/L) 
[23,47,49]. It is hoped that the ongoing PEACE Registry will 
further clarify the relationship between PPCM and selenium 
deficiency. This study aims to describe the relationship between 
selenium deficiency, oxidative stress and PPCM, the impact of 
sodium selenite supplementation on LV reverse remodelling, 
change in New York Heart Association (NYHA) functional class 
and survival in PPCM, and the prevalence of selenium deficiency 
and its relationship with cardiac function in apparently healthy 
pregnant women.[4] 
Clinical outcomes
LV function recovery and mortality rates for PPCM vary widely 
across the globe due to various reasons. Mortality rates as high 
as 24.2% at 6 months and 47.4% at 1 year of follow-up had 
been recorded in Kano, Nigeria, 48.3% over 4 years in Burkina 
Faso, 11.6% over 6 months in Zimbabwe and 13.0% over 6 
months in South Africa (Table 2).[17,20,21,24] In comparison, 
mortality rates were much lower in the United States (4.1% over 
1 year); 2.4% at one month post-hospital discharge in the EORP 
study, in-hospital mortality of 1% in South Korea, and 0% at 6 
months in Germany; possibly a reflection of the higher standard 
of health care.[3,10,39,50] Although some researchers didn’t 
identify any predictors of mortality, others inconsistently reported 
younger age at diagnosis, lower body mass index (BMI) and 
some echocardiographic variables as independent predictors 
of mortality.[20,21,34] Whitehead et al reported that mortality 
increased with maternal age, in women with parity of more than 
4, and in black women, who were 6.4 times more likely to die 
compared with whites.[51] In the IPAC study, 30% of patients 
were Black, and clinical outcomes were significantly worse in 
Black women as only 59% achieved a final LVEF >50% versus 
77% of whites or others, whereas 26% of black women had 
either an event or a final LVEF <35% versus only 8% of whites or 
others (p=0.03).[39] However, in the EORP program, 106 (25.8%) 
patients were Black Africans, but mortality rate at one month 
post discharge did not differ between patients from ESC and 
non-ESC countries (p=0.216).[3]
  
LV reverse remodelling (LVRR) was recently shown to involve both 
LV systolic and diastolic functions, and maximum improvement 
seems to occur within the first 6 months of PPCM diagnosis.
[20,21,23,39] In our cohort, 47.1% satisfied the criteria for LVRR 
while 29.4% recovered LV systolic function at 1 year follow-up; 
somewhat similar to the prevalence of LVRR of 28% over 2 years 
reported from Haiti and of 21% in South Africa over 6 months 
(Table 2).[20,21,34] Blauwet et al found older age and smaller LV 
end-systolic dimension (LVESD) to be significant predictors of LV 
recovery among PPCM patients in South Africa.[20] In addition, 
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“electrical remodelling” in the form of shortening of previously 
broader QRS duration, which is suggestive of improved LV 
function, has also been reported among PPCM patients.[53] 
Right ventricular (RV) systolic and diastolic dysfunction (RVSD 
and RVDD respectively) have been recently studied in PPCM, 
suggesting that the disease is bi-ventricular in nature.[54-57] 
Karaye et al recently reported a prevalence of RVSD (defined 
using tricuspid annular plane systolic excursion) of 71.1% of the 
patients at baseline, which reduced to 36.4% at 6 months and 
18.8% at 1 year.[55] Karaye et al also found RVDD in 69.8%, 
and combined RVSD and RVDD in 58.1% of PPCM patients.
[56] In this study, Selenium deficiency was the only variable that 
significantly determined RVDD, being related to impaired RV 
relaxation in late diastole.[56] In the IPAC study however, results 
showed that RVSD (defined using RV fractional area change) was 
present in only one-third of PPCM patients at baseline, and was 
an independent predictor of subsequent lack of recovery of LV 
function and clinical outcomes including death.[57]
Conclusion
The history of peripartum cardiac failure in Africa dates to the 1960s 
and early-mid 1970s, before the availability of echocardiography. 
To date, there is no population-based PPCM study in Africa to the 
best of our knowledge. However, hospital-based studies have 
reported incidence rates as high as 1:100 deliveries in Nigeria and 
representing up to 52% of all cardiomyopathies. For reasons that 
are not very clear, there are wide disparities in the epidemiology 
of PPCM within and between African Countries. However, 
the disease seems to be more common among the poor rural 
population. With the availability of echocardiography and other 
investigation tools, well characterised PPCM patients have been 
studied in Africa. One of the first studies on RV function in PPCM 
had come from Nigeria, and subsequent studies elsewhere have 
further described the bi-ventricular nature of the disease. Clinical 
outcomes are much worse in Africa than in Western Europe 
and North America. It is hoped that the ongoing peripartum 
cardiomyopathy in Nigeria (PEACE) Registry and the worldwide 
EURObservational Research Programme (EORP) on PPCM will 
soon shed more light on the epidemiology of PPCM in Africa.
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